China Money Network
Login
Join

Qiming, Hillhouse Lead $55M Series C Round In Chinese Biotech Firm Jacobio Pharmaceuticals

  • August 30, 2018 — 13:31 CST

This Data Is Locked!

This area is available only to Subscribers.

Qiming Capital and Hillhouse Capital have led a US$55 million series C round in Jacobio Pharmaceuticals, a Beijing-based clinical stage biotech company. The latest round... [DATA LOCKED]

UNLOCK DATA

Follow the Money & Subscribe for Access to the Best Data and Intelligence on Chinese Venture Capital Deals

Join

Access Thousands of Data Points to Monitor Chinese Private Equity Deal Movement and Relationships

Already Have an Account?

Login
Related Topics:

Related Data: